172 related articles for article (PubMed ID: 38001124)
1. Physico-chemical properties of curcumin nanoparticles and its efficacy against Ehrlich ascites carcinoma.
Rageh MM; Abdelmoneam EA; Sharaky M; Mohamad EA
Sci Rep; 2023 Nov; 13(1):20637. PubMed ID: 38001124
[TBL] [Abstract][Full Text] [Related]
2. Potential anticancer activity and mechanism of action of nanoformulated curcumin in experimental Ehrlich ascites carcinoma-bearing animals.
El-Far M; Salah N; Essam A; Abd El-Azim A; Karam M; El-Sherbiny IM
Nanomedicine (Lond); 2019 Mar; 14(5):553-573. PubMed ID: 30810086
[TBL] [Abstract][Full Text] [Related]
3. In vitro Permeability and Bioavailability Enhancement of Curcumin by Nanoemulsion via Pulmonary Administration.
Shi L; Qu Y; Li Z; Fan B; Xu H; Tang J
Curr Drug Deliv; 2019; 16(8):751-758. PubMed ID: 31722658
[TBL] [Abstract][Full Text] [Related]
4. Curcumin-loaded PLA-PEG copolymer nanoparticles for treatment of liver inflammation in streptozotocin-induced diabetic rats.
El-Naggar ME; Al-Joufi F; Anwar M; Attia MF; El-Bana MA
Colloids Surf B Biointerfaces; 2019 May; 177():389-398. PubMed ID: 30785036
[TBL] [Abstract][Full Text] [Related]
5. Curcumin-polymeric nanoparticles against colon-26 tumor-bearing mice: cytotoxicity, pharmacokinetic and anticancer efficacy studies.
Chaurasia S; Chaubey P; Patel RR; Kumar N; Mishra B
Drug Dev Ind Pharm; 2016; 42(5):694-700. PubMed ID: 26165247
[TBL] [Abstract][Full Text] [Related]
6. Development of curcumin-loaded gemini surfactant nanoparticles: Synthesis, characterization and evaluation of anticancer activity against human breast cancer cell lines.
Karimpour M; Feizi MAH; Mahdavi M; Krammer B; Verwanger T; Najafi F; Babaei E
Phytomedicine; 2019 Apr; 57():183-190. PubMed ID: 30776589
[TBL] [Abstract][Full Text] [Related]
7. Tuftsin-Bearing Liposomes Co-Encapsulated with Doxorubicin and Curcumin Efficiently Inhibit EAC Tumor Growth in Mice.
Murugesan K; Srinivasan P; Mahadeva R; Gupta CM; Haq W
Int J Nanomedicine; 2020; 15():10547-10559. PubMed ID: 33414637
[TBL] [Abstract][Full Text] [Related]
8. Toxicity Reduction and Efficacy Promotion of Doxorubicin in the Treatment of Breast Tumors Assisted by Enhanced Oral Absorption of Curcumin-Loaded Lipid-Polyester Mixed Nanoparticles.
Wang N; Zhang Y; Liu H; Wang A; Ren T; Gou J; Zhang Y; Yin T; He H; Tang X
Mol Pharm; 2020 Dec; 17(12):4533-4547. PubMed ID: 33201717
[TBL] [Abstract][Full Text] [Related]
9. Curcumin nanocrystals self-stabilized Pickering emulsion freeze-dried powder: Development, characterization, and suppression of airway inflammation.
Wang X; Liao Z; Zhao G; Dong W; Huang X; Zhou X; Liang X
Int J Biol Macromol; 2023 Aug; 245():125493. PubMed ID: 37348593
[TBL] [Abstract][Full Text] [Related]
10. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
[TBL] [Abstract][Full Text] [Related]
11. Effects of green synthesised silver nanoparticles (ST06-AgNPs) using curcumin derivative (ST06) on human cervical cancer cells (HeLa) in vitro and EAC tumor bearing mice models.
Murugesan K; Koroth J; Srinivasan PP; Singh A; Mukundan S; Karki SS; Choudhary B; Gupta CM
Int J Nanomedicine; 2019; 14():5257-5270. PubMed ID: 31409988
[TBL] [Abstract][Full Text] [Related]
12. Curcumin-Loaded Hybrid Nanoparticles: Microchannel-Based Preparation and Antitumor Activity in a Mouse Model.
Hong W; Gao Y; Lou B; Ying S; Wu W; Ji X; Yu N; Jiao Y; Wang H; Zhou X; Li A; Guo F; Yang G
Int J Nanomedicine; 2021; 16():4147-4159. PubMed ID: 34168445
[TBL] [Abstract][Full Text] [Related]
13. High drug payload curcumin nanosuspensions stabilized by mPEG-DSPE and SPC: in vitro and in vivo evaluation.
Hong J; Liu Y; Xiao Y; Yang X; Su W; Zhang M; Liao Y; Kuang H; Wang X
Drug Deliv; 2017 Nov; 24(1):109-120. PubMed ID: 28155567
[TBL] [Abstract][Full Text] [Related]
14. Formulation design and photochemical studies on nanocrystal solid dispersion of curcumin with improved oral bioavailability.
Onoue S; Takahashi H; Kawabata Y; Seto Y; Hatanaka J; Timmermann B; Yamada S
J Pharm Sci; 2010 Apr; 99(4):1871-81. PubMed ID: 19827133
[TBL] [Abstract][Full Text] [Related]
15. Lipid- and Polymer-Based Nanostructures for Cutaneous Delivery of Curcumin.
Caon T; Mazzarino L; Simões CM; Senna EL; Silva MA
AAPS PharmSciTech; 2017 Apr; 18(3):920-925. PubMed ID: 27230504
[TBL] [Abstract][Full Text] [Related]
16. Development of Curcumin-Loaded Solid Lipid Nanoparticles Utilizing Glyceryl Monostearate as Single Lipid Using QbD Approach: Characterization and Evaluation of Anticancer Activity Against Human Breast Cancer Cell Line.
Bhatt H; Rompicharla SVK; Komanduri N; Aashma S; Paradkar S; Ghosh B; Biswas S
Curr Drug Deliv; 2018; 15(9):1271-1283. PubMed ID: 29732970
[TBL] [Abstract][Full Text] [Related]
17. Co-delivery of etoposide and curcumin by lipid nanoparticulate drug delivery system for the treatment of gastric tumors.
Jiang H; Geng D; Liu H; Li Z; Cao J
Drug Deliv; 2016 Nov; 23(9):3665-3673. PubMed ID: 27749102
[TBL] [Abstract][Full Text] [Related]
18.
Huang C; Chen F; Zhang L; Yang Y; Yang X; Pan W
Int J Nanomedicine; 2020; 15():2987-2998. PubMed ID: 32431497
[TBL] [Abstract][Full Text] [Related]
19. Oral nanoparticulate curcumin combating arsenic-induced oxidative damage in kidney and brain of rats.
Sankar P; Telang AG; Kalaivanan R; Karunakaran V; Suresh S; Kesavan M
Toxicol Ind Health; 2016 Mar; 32(3):410-21. PubMed ID: 24105067
[TBL] [Abstract][Full Text] [Related]
20. Preparation of curcumin-loaded cochleates: characterisation, stability and antioxidant properties.
Chen L; Yue B; Liu Z; Luo Y; Ni L; Shen W; Zhou Z; Ge X
Food Funct; 2022 Oct; 13(21):11273-11282. PubMed ID: 36226565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
